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The genetic programs specifying eye development are highly conserved during evolution and involve the vertebrate Pax-6
gene and its Drosophila melanogaster homolog eyeless (ey). Here we report that the SR protein B52/SRp55 controls a novel
developmentally regulated splicing event of eyeless that is crucial for eye growth and specification in Drosophila. B52/SRp55
generates two isoforms of eyeless differing by an alternative exon encoding a 60-amino-acid insert at the beginning of the
paired domain. The long isoform has impaired ability to trigger formation of ectopic eyes and to bind efficiently Eyeless target
DNA sequences in vitro. When over-produced in the eye imaginal disc, this isoform induces a small eye phenotype, whereas
the isoform lacking the alternative exon triggers eye over-growth and strong disorganization. Our results suggest that B52/
SRp55 splicing activity is used during normal eye development to control eye organogenesis and size through regulation of
eyeless alternative splicing.
Citation: Fic W, Juge F, Soret J, Tazi J (2007) Eye Development under the control of SRp55/B52-Mediated Alternative Splicing of eyeless. PLoS ONE 2(2):
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INTRODUCTION
Alternative splicing enables metazoan genomes to expand their
coding capacities through synthesis of different mRNAs from
single genes [1]. It has been estimated that approximately 40%
and 74% of Drosophila and human genes, respectively, encode
alternatively spliced pre-mRNAs [2,3]. It is, therefore, anticipated
that alternative splicing participates in the regulation of the gene-
expression program that is required for multi-cellular organism
development [4,5]. However, for many genes, the evidence for
a change in function due to the generation of alternatively spliced
transcripts is based solely on analysis of the mRNA transcripts,
with no confirmation that distinct protein isoforms are expressed in
vivo [6,7]. Also, isoform-specific targeting has been performed only
in few cases to gain insight into how the function and expression of
the protein isoforms differ in physiological context [4,8,9]. Most of
our knowledge about alternative splicing mechanisms has been
gleaned from use of model minigene reporters [4,10], however,
much less is known about the capacity of specific splicing factors to
influence specific developmental programs.
Among the splicing factors involved in splice site choice,
members of the SR (Ser/Arg-rich) family of proteins play a major
role [11–14]. These proteins constitute a family of splicing factors
that are highly conserved in multi-cellular organisms [15,16].
They have a modular structure that consists of one or two RNA-
recognition motifs (RRMs) and a carboxyl (C)-terminal argini-
ne(R)/serine(S)-rich domain (the so-called RS domain). SR
proteins participate both in constitutive and alternative splicing
by recruiting the general splicing machinery to splicing signals and
by binding to regulatory elements in the pre-mRNA [14,17,18].
These splicing functions are modulated by antagonistic factors
[19–21] and phosphorylation of serine residues located within the
RS domain [14,22]. SR proteins can, therefore, affect usage of
alternative 59 or 39 splice sites in a concentration-dependent
manner [23–27].
The physiological relevance of members of the SR protein
family became apparent with the realization that they are essential
for cell viability and/or animal development in different model
systems [15,21,28–32]. The specific role(s) that individual SR
proteins play in specific physiological and developmental pro-
cesses, however, is (are) largely unknown. The Drosophila eye
organogenesis provides an excellent system to identify general
molecular mechanisms regulating specific developmental steps
[33]. Interestingly, several well characterized genes that function at
the early steps of eye development encode different splice variants.
Among these genes, eyeless (ey), dachshund (dac), eyes absent (eya), and
eygone (eyg) have the capacity to activate the program that is
responsible for eye formation when their expression is ectopically
targeted to imaginal discs of Drosophila other than the eye [33,34].
Homologs of these genes also play a primordial role in vertebrate
eye development, revealing that evolutionarily conserved genes are
involved in determining the different eye types in the various
metazoan phyla [34]. They are, therefore, considered as master
genes of eye development.
Here we report that the SR protein B52/SRp55 controls
a critical splicing event of eyeless pre-mRNA that changes the
biochemical and physiological properties of the encoded protein
isoforms. Binding of B52/SRp55 to exonic sequences in the first
intron of eyeless pre-mRNA allows production of a novel de-
velopmentally regulated protein isoform with additional 60 amino-
acids immediately upstream from the DNA binding domain
(paired domain). Over-production of this novel isoform in the eye
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PLoS ONE | www.plosone.org 1 February 2007 | Issue 2 | e253results in small eye phenotype, whereas the canonical Eyeless
induces eye over-growth. These results show for the first time that
a splicing factor, namely, B52/SRp55 directs eye size through
production of two alternatively spliced isoform of Eyeless a master
control gene for morphogenesis.
RESULTS
B52 gain of function alters eye development
B52 activity is critical for Drosophila development as both loss of
function and gain of function lead to lethality [35]. By using the
GAL4/UAS binary expression system [36] to drive expression of
B52 in a tissue-specific manner, it was possible to obtain viable
adults harboring phenotypes in the eye (GMR-gal4 driver) or in
bristles (HS-gal4 and sca-gal4 drivers) [21]. B52 Over-expression
under the control of the eyeless-GAL4 (ey-GAL4) driver, which
directs expression to the primordial eye disc in embryos and the
imaginal eye disc [37], profoundly affected eye development
(Fig. 1). When UAS-B52 females are mated to ey-gal4 males, only
40% of the progeny reached the adult stage. 45% of surviving flies
had reduced eye size (Fig. 1A, panel c and Fig. 1B, panel b) and
10% lacked one eye (Fig. 1A, panel d and Fig. 1B, panels c and d).
Strikingly, these defects are reminiscent of phenotypes associated
with eyeless mutations that disrupt an eye-specific regulatory
element of the eyeless (ey) gene [38], suggesting that B52 Over-
expression may alter ey expression. The observed phenotypes
appear to be specific for B52 Over-expression because relatively
weak defects of retinal development or no phenotypes are
observed with another SR protein, dASF, when overexpressed
by the same driver using UAS-dSF2 lines (data not shown). Both
western-blotting and semi-quantitative reverse transcription (RT)-
PCR of RNA from eye imaginal disc confirmed this assumption
and demonstrated that in transgenic flies the over-expression of
B52/SRp55 did not exceed 2 fold compared to wild type (not
shown). Thus, moderate excess of B52/SRp55 in developing eyes
gives rise to the same phenotype as low levels of eyeless gene
expression. However, quantitative RT-PCR failed to demonstrate
dramatic changes in eyeless total mRNA levels in B52/SRp55
transgenic flies compared to wild type. The expression levels of
other master genes involved in eye formation were also not
detectably changed.
B52 levels affect alternative splicing of
developmentally regulated eyeless gene
Failure to find quantitative changes in eyeless expression levels
prompted us to test whether qualitative changes occurred that
could account for the observed phenotypes associated with B52
over-production. While most studies about eyeless gene function
have considered only one isoform encoded by this gene, one report
in the literature alluded to isolation of a cDNA that encodes
a longer isoform [37]. The latter isoform is also present among
ESTs described in the fly Database and corresponds to inclusion of
an exonic sequence contained in the first intron of the previously
Figure 1. Over-expression of B52 under the control of the ey-Gal4 transgene impairs eye development. (A) Scanning electron microscope images of
wild-type flies (a, e) and UAS-B52/+; ey-gal4/+flies (ey.B52) (b–d, f and g). Photographs were taken at 1406(a–d) and 9006(e–g). (B) ey.B52 flies
display variable eye phenotypes ranging from small reductions to absence of the eye (a–d).
doi:10.1371/journal.pone.0000253.g001
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Drosophila species revealed that the intron/exon structure of the
eyeless gene is highly conserved and all contain similar exonic
sequences in the first intron (not shown). This exon codes for
protein fragment that is higly conserved at the beginning and final
third with a central region that is less conserved (Fig. 2B). RT-
PCR analysis of RNA from D. melanogaster and D. virilis revealed
that this exon is alternatively spliced in these two fly species
(Fig. 2C). Together these observations suggest that the longer
splice variant carries out an essential function that depends on
alternative splicing. Here we refer to the isoform including exon 2
as ey(2a).
Previous results identified the spliced form ey(2a) in embryos
and larvae [37], however, the levels of individual ey and ey(2a)
isoforms were not compared at the different developmental stages.
Therefore, mRNA products of eyeless gene were examined by
RT-PCR and normalized to ribosomal Rp49 mRNA at different
developmental stages (Fig. 2D). Both larvae and pupae contained
larger amounts of ey(2a) than ey mRNA (Fig. 2D, lanes 2–3). In
contrast, embryos and adult flies had almost equal levels of both
types of mRNA (Fig. 2D, lanes 1 and 4). To determine whether
these two isoforms are expressed in different tissues or are co-
expressed in the same tissues, we analysed their distribution in two
larval tissues. In third instar larvae, ey is expressed in the eye disc
and in the brain. RT-PCR analysis on these two isolated tissues
revealed that both ey isoforms are co-expressed in these tissues
(Fig. 2D, lanes 5 and 6). Albeit, both tissues contained larger
amounts of ey(2a) than ey mRNA. Moreover, cultured SL2 cells
expressed both isoforms (see below, Fig 3C), suggesting that they
are expressed in the same cells.
Figure 2. Conservation of eyeless exon 2 alternative splicing. (A) Genomic organization of the D. melanogaster eyeless gene. Alternative inclusion of
exon 2 (left panel, black box) generates the Ey(2a) isoform that contains 60 additional amino acids (right panel, black box) upstream from the paired
domain (right panel, grey box) compared to the canonical Ey isoform. The homeodomain is shown as the hatched box. (B) Sequence comparison of
the first 150 amino acids of the Ey(2a) isoform in four Drosophila species. D. melanogaster exon 2 sequence was used to blast the first intron of the ey
gene in the three other species. Predicted protein sequences were deduced from the following genomic scaffolds: AE003843 (D. melanogaster),
AAPP01017013 (D. ananassae), CH475402 (D. pseudoobscura), CH940665 (D. virilis). The protein sequences derived from exon 2 are between the
brackets. (C) eyeless exon 2 is alternatively spliced in D. virilis and D. melanogaster. RT-PCR with primers in exon 1 and 3 of ey was performed on total
RNA from D. virilis (lane 1) and D. melanogaster (lane 2) larvae. (D) ey alternative splicing during D. melanogaster development. RT-PCR with primers in
exon 1 and 3 of ey was perfomed on total RNA from D. melanogaster at various developmental stages and in different tissues of third instar larvae.
doi:10.1371/journal.pone.0000253.g002
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imaginal disc, we asked whether B52 over-expression under the
control of ey-gal4, which triggers the phenotypes depicted in Fig. 1,
can perturb exon 2 inclusion. RT-PCR analyses, using primers
that discriminate exon 2 inclusion (Fig. 3A, panel ey(2a)) from
exon 2 skipping (Fig. 3A, panel ey), on WT and ey.B52 eye
imaginal discs showed that exon 2 inclusion is increased by B52
over-expression (Fig. 3A, all panels compare lanes 1 and 2),
suggesting that B52 is involved in exon 2 splicing. To further
investigate this hypothesis, we asked whether B52 loss of function
can affect ey exon 2 alternative splicing. To this end, we took
advantage of a B52
s2249 mutant that contains a P{lacW} transgene
inserted 16 nt downstream from the B52 transcription start site
(Flybase). B52
s2249 homozygous larvae die at the first- and second-
instar larval stage ([39] and present study), similar to the B52
28 null
larvae [30]. Absence of B52 mRNA was confirmed by RT-PCR
analysis of RNA extracted from living B52
s2249/B52
s2249 larvae
(Fig. 3B, lane 2). RT-PCR analyses with eyeless-specific primers
revealed, however, that B52 depletion is correlated with a reduc-
tion in the ey(2a) mRNA isoform and with a parallel increase in the
expression level of ey mRNA (Fig. 3B, lower left panel compare
lanes 1 and 2). Quantitation with primers that distinguish between
Figure 3. B52 regulates alternative splicing of eyeless in vivo. (A) RT-PCR analysis of eyeless expression in wild type (lane 1) and ey.B52 (lane 2) eye
imaginal discs at the third instar larval stage. RT-PCR was performed with primers specific for each isoform. (B) RT-PCR analysis of ey exon 2 inclusion
in wild-type (lane 1) and B52
s2249 mutant (lane 2) second instar larvae. The right panel corresponds to quantitation of ey exon 2 splicing in B52
s2249
normalized to wild-type (WT). RT-PCR was performed in triplicates with primers specific for ey isoform (exon 1–3), ey(2a) isoform (exon 2), or both
(exon 9); and expression was normalized to the RP49 level. The expression level in WT was arbitrary set up to 1. Quantitation with primers specific for
ey exon 9 showed that the global level of eyeless expression does not change in B52
s2249 mutant background. (C) SL2 cells were treated with dsRNA
against dASF (lane 1) or B52 (lane 2) or untreated (lane 3), and analyzed by RT-PCR (top panel) or western blotting (bottom panel). (D) Cross-linking of
exon 2 sequences to B52. Radiolabelled probes corresponding to contiguous sequences of exon 2, named a, b and c were incubated in Kc nuclear
extracts and exposed to UV light. A high affinity binding site for B52 (BBS) was used as a positive control. Autoradiography of the SDS-PAGE (left
panel) shows that probes a (lane 1) and b (lane 2), as well as BBS (lane 4), predominantly cross-link a 52 kDa protein. Cross-linking of BBS to 52 kDa
protein was efficiently competed by increasing amounts of unlabelled probes a (right panel; lanes 6 and 7) and b (lanes 8 and 9) but not c (lanes 10
and 11). (E) RNA probes a (lane 1), b (lane 2), c (lane 3) and BBS (lane 5) were covalently bound to beads and incubated with Kc nuclear extract. After
washing, beads were loaded on an SDS-PAGE and transferred to nitrocellulose. The membrane was probed with anti-dASF (panel dASF) and anti-B52
sera (panel B52). Beads alone (lane 4) and Kc nuclear extract alone(lane 6) were run as controls.
doi:10.1371/journal.pone.0000253.g003
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concomitant with a two fold decrease the ey(2a) isoform (Fig. 3B,
right panel). These results demonstrate that B52 contributes to the
production of ey(2a) isoform in whole second-instar larvae.
Exon2 of eyeless contains B52 binding sequences
To further confirm the involvement of B52 in regulating eyeless
alternative splicing, we employed RNA interference in Drosophila
SL2 cells. We observed that SL2 cells express both ey isoforms in
a ratio similar to that observed in brain and eye tissues (Fig. 3C).
Cells were incubated with B52 double-stranded RNA, and the
level of B52 protein was determined by western blot analysis
(Fig. 3C, panel B52). As a control, cells were treated in parallel
with dASF-specific dsRNA (Fig. 3C, panel dASF). Following six
days of treatment, each dsRNA efficiently and specifically depleted
the corresponding protein (Fig. 3C, compare panels B52 and
dASF to panel a-tubulin). RT-PCR analyses of dsRNA-treated
cells showed that B52 depletion triggered a significant decrease in
ey(2a) mRNA levels with a concomitant increase in ey mRNA levels
(Fig. 3C, upper panel lane 2), whereas dASF depletion had no
effect (Fig. 3C, upper panel lane 1). Depletion of either B52 or
dASF, however, did not affect the expression of a specific isoform
of doublesex (Fig. 3C, panel dsx lanes 1–3), known to be regulated by
SRp20, another member of the SR protein family. Altogether our
results show that varying the B52 level in vivo modulates exon 2
inclusion and provides strong evidence that B52, but not another
SR protein, is required for ey exon2 inclusion.
Sites on RNA that bind B52 with high affinity and specificity
(BBS) have previously been described [40]. When RNA aptamers
containing multi-mers of these BBS were expressed in transgenic
flies under the same genetic driver of B52 over-production, they
fully restored wild type phenotypes, implying that B52 binds to its
target sequences in vivo to regulate alternative splicing. To test
whether exon 2 of eyeless contains sequences recognized by B52,
UV crosslinking experiments were performed under splicing
conditions using Kc cells nuclear extracts as a source of B52
protein and three probes corresponding to contiguous sequences of
exon 2, named (a), (b) and (c), which cover its entire length.
Radiolabeled probes (a) and (b) bound to a ,52 kDa band
(Fig. 3D, lane 1–2), which was also detected with a radiolabeled
probe corresponding to the B52 high affinity binding site
established by SELEX [40] that was used as positive control
(Fig. 3D, lane 4), making it very likely that the protein
corresponded to B52. The identity of the protein was further
confirmed using RNA affinity selection procedure on (a), (b) and
(c) fragments, where B52 was detected by anti-B52 antibodies
(Fig. 3E). Both (a) and (b) but not (c) RNA fragments are able to
bind B52 (Fig. 3E, panel B52 lanes 1–3). Neither fragment,
however, showed binding to dASF which, like B52, contains two
RRMs (Fig. 3E, panel dASF, lanes 1–3). Consistent with these
results, competition experiments showed that the (a)- and the (b)-
exon 2 sequences competed with the crosslinking of B52 high
affinity binding site (BBS) whereas (c)-type sequence did not
(Fig. 3D, lanes 5–11), confirming that both (a) and (b) sequences
behave as B52 binding sites. These data provide further evidence
that B52 regulates eyeless exon 2 inclusion through specific binding
of exon 2 sequences.
High level of Ey(2a) and Ey differentially affect eye
growth
Because high levels of B52 in the eye are expected to result in
increased concentration of Ey(2a) compared to Ey isoform, we
were interested to determine the functional consequences of over-
producing Ey(2a) on eye development and/or morphogenesis. To
this end, we expressed either ey or ey(2a) cDNAs with the UAS/
Gal4 system. Reproducibly, when expressed in the eye disc under
the control of the ey-gal4 driver, Ey(2a) induced formation of small
eyes that are the result of reduced number of ommatidia (Fig. 4A,
panels c and f). However, all the structures of the ommatidia were
present (panel i), implying that Ey(2a) does not interfere with
normal process of differentiation of the eye but limits its size. In
contrast, expression of the Ey isoform led to more variable
phenotypes ranging from a small reduction and disorganization
of the eye (Fig. 4A, panels b, e and h, and [41]) to over growth
(Fig. 4b). Quantization of these results indicated that small changes
in the amount (1.5 to 2 fold) of either isoform were responsible for
the observed phenotypes. Given that B52 also regulates splicing in
a dose-dependent manner, these results confirmed our finding that
B52 finely tunes eye organogenesis by controlling the amount of
these splice variants.
The ey gene is a master control gene for eye morphogenesis,
because the Ey isoform of the gene has the ability to induce ectopic
eye structures in several imaginal discs [42,43]. Therefore, we
decided to study the potential of Ey(2a) to induce ectopic eyes by
using the Gal4 system to target its expression to imaginal discs
where it is normally not transcribed. Comparison of phenotypes
induced by MS1096, which allows specific expression of either Ey
or Ey(2a) in the wing disc [44], revealed that Ey(2a) was less
efficient to trigger ectopic eye structures in the adult wings than Ey
(Fig. 4B, compare panels a and b). The eye structures reproducibly
were smaller in size with Ey(2a) in comparison to those obtained
with the Ey isoform. This observation was further confirmed using
the dpp-Gal4 driver, which is expressed in all imaginal discs. Again,
more pronounced eye morphogenesis was obtained with the Ey
isoform than with Ey(2a) where only small foci of unstructured
ommatidia were observed (data not shown).
Ey(2a) is less potent than Ey in activating
transcription of target genes and in binding to
cognate DNA sequences
The above results are consistent with the hypothesis that Ey and
Ey(2a) have distinct function(s) during eye morphogenesis. As
several genes are under the control of the ey gene to switch on the
eye development pathway, it is conceivable that Ey and Ey(2a)
isoforms differ in their ability to activate target genes. To test this
hypothesis, we determined the expression level of specific target
genes after ectopic expression of either isoform in the wing disc.
We considered well-characterized direct targets of Ey, eyes absent
(Eya) and shifted (shf), which were examined using in situ hybridi-
zation, gel shift assays, and reporter analysis [45,46]. We also
examined expression of Sine oculis (so), a subordinate regulatory
gene that mediates ey gene activation [45–47]. As a negative
control, we used optix (opx) whose transcription is not induced by
Ey [48]. RT-PCR analysis demonstrated that while both ey(2a)
and ey isoforms were overexpressed to similar extent (Fig. 4C,
panel ey), induction of ey-target genes mediated by Ey(2a) was
lower compared with Ey (Fig. 4C, compare lanes 2 and 3 of each
panel). As expected neither isoforms stimulated transcription of
optix gene (Fig. 4C, panel opx), confirming the specificity of
induction of the direct target genes.
The differences in expression of the target genes could be
explained if Ey(2a) and Ey isoforms exhibited different affinities for
target DNA sequences. The Ey protein contains two DNA binding
domains, a paired domain (PD) and a paired-type homeodomain
(HD) both of which are capable of binding specific DNA
sequences. Only PD, but not HD, protein has been shown to be
Eyeless Alternative Splicing
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additional amino-acids immediately upstream from its paired
domain, it is possible that this modification affects its binding
ability and/or specificity. To directly test these possibilities, the
two Ey paired domains (denoted PD and PD(2a)) were expressed
in E. coli as gluthatione S-transferase (GST) fusion proteins
(Fig. 5A), and their DNA binding abilities were examined by
electrophoretic mobility shift assay (EMSA). In the presence of
a large excess (200 fold) of cold competitor, the extended paired
domain PD(2a) did not bind to CD19-2, the high affinity binding
site for the shorter eyeless paired domain [50], (Fig. 5B, compare
lanes 3 and 7). PD(2a) also bound less efficiently to other paired
domain recognition sites, including sowt3, a sequence found
upstream of so and demonstrated to regulate its transcription by
Eyeless [51] (Fig. 5B, compare lanes 4 and 8, and Fig. 5C, right
panel for quantitative comparison). Weak binding affinity was also
demonstrated for P6CON, a high affinity binding site for Pax6
[52], the human homolog of Eyeless (Fig. 5B, compare lanes 1 and
5, and Fig. 5C, left panel for quantitative comparison). The
specificity of binding of recombinant proteins to these sequences
was observed, however, when increasing amounts of unlabeled
probes were added and showed to compete with themselves in the
Figure 4. Over-expression of Ey(2a) and Ey isoforms leads to different phenotypes. (A) Representative eye phenotypes obtained after expression of Ey
(panel b) or Ey(2a) (panel c) isoforms under the control of ey-Gal4, compared to wild-type flies (panel a). Ey isoform expression induces strong
disorganization of the ommatidia lattice (compare panels e and d). Ommatidia appear of variable size with possible fusion between them, as
observed in (panel h). ey.Ey flies often display local overgrowth in the eyes (arrowhead in panel b). Expression of the Ey(2a) isoform only reduces the
size of the eye (panels c and f) with moderate disorganization of the omatidia lattice (panel i). (B) Expression of Ey (panel a) and Ey(2a) (panel b)
isoforms under the control of MS1096. (C) Ectopic expression of Ey and Ey(2a) in the wing induces expression of downstream target genes at different
levels. RT-PCR analyses were performed to measure the expression of eyeless (panel ey), the ribobosomal Rp49 (panel rp49), Sine oculis (panel so), eyes
absent (panel eya), shifted (panel shf) and Optix (panel opx) mRNAs in wing discs from wild type (lane 1) MS1096.Ey (lane 2) and MS1096.Ey(2a)
(lane 3) third instar larvae.
doi:10.1371/journal.pone.0000253.g004
Eyeless Alternative Splicing
PLoS ONE | www.plosone.org 6 February 2007 | Issue 2 | e253presence of large excess of competitor (Fig. 5D, left and right
panels).
Since P6CON sequence was also refractory for binding the
paired domain of Pax6(5a), a Pax6 isoform with a 14-amino-acid
insertion in the paired domain that arises by alternative splicing
(Epstein et al., 1994), it was important to determine whether
PD(2a) has the same specificity as Pax6(5a). EMSA assays were,
therefore, performed with 5aCON, a sequence that selectively
binds Pax6(5a) paired domain [52]. As previously observed,
5aCON did not have a high affinity for PD(2a) compared to PD
(Fig. 5B, compare lanes 2 and 6). Furthermore, while 5aCON
changed the EMSA binding profile of Pax6(5a) paired domain
[52], no changes in gel shift were observed with PD(2a). Together,
these results suggest that the 60 additional amino-acids at the N-
terminal part of the paired domain of eyeless weaken its DNA
binding activity.
DISCUSSION
In this work, we show that B52, an SR protein splicing factor,
controls the production of two alternatively spliced isoforms ey and
ey (2a) of eyeless, a master control gene for eye morphogenesis. Our
data not only establish the mechanistic link between a splicing
factor and a critical component of eye development, but also
Figure 5. In vitro DNA binding activities of Ey and Ey(2a) paired domains. (A) SDS-PAGE of GST-PD and GST-PD(2a) fusion proteins that were
expressed and purified from bacteria. (B) EMSA performed with GST-PD (lanes 1–4) or GST-PD(2a) (lanes 5–8) in the presence of four established
consensus sequences P6CON (lanes 1 and 5), 5aCON (lanes 2 and 6), CD19-2 (lanes 3 and 7) and sowt3 (lanes 4 and 8) for Ey or its human homolog
PAX6 or PAX6(5a) isoform. See text for details. (C) EMSA of P6CON (left panel) and sowt3 (right panel) probes in the presence of increasing amounts
of GST-PD (1 ng, lane 1; 5 ng, lane 2; 50 ng, lane 3; 200 ng, lane 4) and GST-PD(2a) (1 ng, lane 5; 5 ng, lanes 6, 50 ng, lane 7; 200 ng, lane 8) proteins.
(D) EMSA of P6CON (left panel) and sowt3 (right panel) probes with 50 ng of GST-PD (lanes 1–4) or GST-PD(2a) (lanes 5–8) in the presence of (1 fold,
lanes 2 and 6; 2 fold, lanes 3 and 7; 10 fold, lanes 4 and 8) of unlabelled corresponding probes or without competitor (lanes 1 and 5).
doi:10.1371/journal.pone.0000253.g005
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the ey isoform has been extensively studied, and its ectopic
expression shown to induce functional eyes on the legs, wings, and
antennae of the fly [42]. Here we demonstrate that ey and ey(2a)
isoforms generated by alternative splicing are co expressed
throughout Drosophila development. The importance of this
splicing event for eye formation is underscored by its conservation
among several Drosophila species and its involvement in changing
the DNA binding properties of a hallmark feature of Pax gene
family, the PD domain. Unlike Ey, Ey(2a) has an impaired ability
to trigger efficient ey target gene expression and to bind efficiently
to DNA cognate sequences. Intriguingly, our data further suggest
that ey(2a) is apparently acting in a dominant-negative fashion
toward ey. Over-production of ey(2a) in the eye causes a small eye
phenotype, whereas, under the same conditions ey overproduction
produces local eye over-growth. Thus, during eye formation, small
changes in the ey/ey(2a) equilibrium may ensure a correct number
of ommatidia and thereby control eye morphogenesis. In this
context, it may be relevant that the activity of the eyeless gene is
adjusted by a splicing event producing two isoforms with
antagonistic activities rather than a transcription factor, like twin
of eyeless (toy), that may turn it on and off in a more restricted way
[53].
Our data also provide support for the idea of a direct connec-
tion between pre-mRNA splicing and eye development being
conserved from Drosophila to mammals [33,38]. As in vertebrates,
where the single Pax6 gene produces two alternatively splicing
isoforms, referred to as Pax6 and Pax6(5a) that exhibit distinct
functions [52], the eyeless gene also encodes two isoforms with
different transcriptional properties. In the case of the Pax 6 gene,
alternative splicing generates two transcripts that differ in the
inclusion of 14 amino acids encoded by the additional exon 5a
[52]. This insertion occurs immediately N-terminal of an a-helix
that is important for the recognition of specific DNA sequences by
the PD domain and thereby profoundly alters its DNA-binding
activity [52]. When tested on the well-known bipartite paired
domain recognition sequences both ey(2a) and Pax6(5a) PD
domains fail to bind [53]; this study). However, Pax6(5a) but not
Ey(2a) could interact with the highly specialized recognition
sequence 5aCON ([52], this study), suggesting that Ey(2a) might
have a different specificity from Pax6(5a). Alternatively, additional
amino acids N-terminal to PD domain of Ey(2a) may mask the
PD domain and thus prevent its interaction with target DNA
sequences. Future experiments are needed to establish the struc-
ture of the Ey(2a) PD domain with its additional N-terminal amino
acids and to more definitively test whether Ey(2a) activates target
genes other than those recognized by Ey and/or mediates
assembly of different transcriptional complexes to exhibit distinct
transcriptional activation properties.
Our experiments suggest that one of the functions mediated by
B52 during Drosophila eye development is to attenuate the effect of
an over-expression of ey that could be detrimental for eye
morphogenesis. This proposal stems from the ectopic expression
experiments showing that over-expression of B52 is associated with
partial or complete loss of the eye, a phenotype that is equivalent
to inactivation of an eye-specific enhancer of the eyeless locus by
transposon insertion [37]. Further support comes from B52
depletion experiments showing a two fold reduction of ey(2a)
and concomitant increase of ey mRNA levels. However, the eyeless
alternative splicing event was not identified in large scale analysis
of alternatively spliced pre-mRNAs that are aberrantly regulated
in B52-deficient tissue culture cells [54]. Given that previous
studies have used a robust system to select alternative splicing
events and only weak expression of eyeless was detected in SL2
cells (present study), it is likely that the two fold changes in the ey/
ey(2a) ratio was below the threshold to be detected by Blanchette et
al. [54]. Thus, genetic and biochemical analyses like the ones
described in this paper appear to be essential to decipher the
function of specific isoforms, whose levels are moderately altered
during Drosophila development.
The exact mechanism by which B52 influences alternative
splicing of eyeless pre-mRNA is still unknown. In vitro data showed
that B52 binds directly the alternative exon 2 and mediates its
inclusion. However, computational scanning of the target exonic
sequence for previously reported SELEX consensus RNA binding
sequence recognized by B52 [55,40], failed to reveal any match to
this sequence, suggesting that B52 interacts with a set of distinct
RNA sequences to regulate the eyeless splicing event. It is also
possible that, as with other RNA binding proteins [14,17], eyeless-
regulated splice sites require the formation of large, multi-protein
complexes compatible with the requirement for a higher order
of complexity, rather than a single RNA-protein interaction.
Identification of partners assembled in these complexes will be
informative about mechanism(s) leading to tissue-specific regula-
tion of eyeless alternative exon 2. We cannot completely rule out the
possibility, however, that deregulation of eyeless alternative splicing
in both B52
- larvae and in B52 RNAi-mediated knock down in
SL2 cells may be due to an indirect effect. But failure to observe
similar splicing phenotype associated with either over expression
or depletion of another SR protein, dASF, further supports the
idea that eyeless alternative splicing is specifically mediated by
direct interaction of B52 with exon 2 sequences.
B52 deficiency does not seem to induce major defects in growth
and differentiation of the eye disc during larval stage [39] and does
not abolish eyeless pre-mRNA splicing, but rather makes a specific
contribution to its regulation during eye morphogenesis. During
the larval period, a wave of differentiation and patterning called
the morphogenetic furrow (MF) progresses from posterior to
anterior across the disc epithelium [56]. Anterior to the furrow are
the dividing, undifferentiated progenitor cells; immediately behind
the furrow, cells form differentiating clusters; and more posterior,
these clusters acquire their final differentiated state [34]. Eyeless is
expressed throughout the undifferentiated progenitor cells at the
anterior part of the eye imaginal disc, and its expression is down-
regulated in the MF where cells are held in G1 [34]. B52 may act
directly on the progression of the MF, as it has been recently
shown to maintain the G1/S block in vivo by specific regulation of
the repressor function of dE2F2 [39]. It is possible that B52-
mediated eyeless splicing is regulated at the entry of the MF to
control the number of ommatidia founder cells. Further insights
into specific regulation of ey pre-mRNA splicing by B52 will likely
require identification of signaling pathways that modulate the level
of B52 and/or activity at the MF. Among these signalling
pathways Hedgehog (Hh) [57], Dpp, a secreted molecule [58] and
the Notch pathway are known to be important for eye
development [59].
MATERIALS AND METHODS
Drosophila stocks
eyeless cDNA E10 cloned in pUAST vector was provided by W.
Gehring (Biozentrum der Universitat Basel, Basel, Switzerland).
To obtain the pUAST-Ey(2a) construct, ey cDNA E10 was cloned
into the XhoI/XbaI sites of the pSP72 vector (Promega). A 493 nt
NcoI/NaeI fragment was replaced by a 672 bp NcoI-NaeI
fragment containing exon 2a. This 672 bp NcoI-NaeI eyeless
cDNA fragment was amplified with high fidelity Pfu polymerase
from larval cDNAs and subcloned into the TOPO–TA PCRII
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its integrity. The 2.8 kb XhoI-XbaI fragment containing ey(2a)
cDNA was inserted into the pUAST vector. pUAST-Ey(2a) and
pUAST-Ey plasmids were used to transform w
1118 flies according
to standard protocols [58]. The transposon integration sites were
mapped to individual chromosomes by standard crosses using
balancer stocks. Five independent UAS-Ey and UAS-Ey(2a)
transgenic lines were analysed in all experiments. Gal4 lines and
the B52
s2249 line were obtained from the Bloomington Drosophila
Stock Center. All crosses were reared at 25uC on standard medium.
RNA extraction and RT-PCR
Total RNA was extracted from cultured cells or larval tissues using
TRI Reagent (Sigma Aldrich) and treated with RNase-free DNase
I. cDNA was synthesized with First Strand cDNA kit (Amersham
Pharmacia) using an oligo-(dT) primer. PCR products were separ-
ated by agarose gel electrophoresis and visualized by ethidium
bromide staining. Sequences of the primers are available upon
request.
RNAi
RNA interference treatments were performed in SL2 cells accord-
ing to Worby et al. (2001). Cells were treated with double-stranded
RNA corresponding to the entire coding sequence of B52/Srp55
or dASF at day 1 and harvested on day 6 for western and RT-
PCR analysis.
Antibodies
The Anti-dASF and Anti-B52 sera against the peptide
GSYRGGNRNDRSRD corresponding to aa 85 to 98 of Drosophila
dASF, and to the peptide KNGNASPDRNNESMDD at the C-
terminal end of B52, respectively were raised in rabbits by
Eurogentec.
GST constructs and gel shift
The N-terminal region of Eyeless corresponding to the paired
domain (PD) or to the PD with the region encoded by exon 2a
were cloned into the NotI –SalI sites of pGEX-5x vector to give
the GST-PD or GST-PD(2a) constructs respectively. GST-fusion
proteins were produced in E. coli strain BL21(DE3) and were
purified according to standard protocols. Double-strand DNA
probes were obtained by mixing complementary oligonucleotides
and were radiolabelled at their 59-end with c-
32P ATP. Binding
assays contained approximately 0.5 ng of DNA probe and varying
concentrations (0.5–200 ng) of purified GST-PD or GST-PD(2a)
proteins. Gel shift reactions were performed in 25 mM Hepes
(pH 7.6), 10% glycerol, 100 mM KCl, 1 mM DTT 1% NP40,
0,1% BSA, 2006DNA competitor. DNA-protein complexes were
resolved on 6% polyacrylamide gels in 0.56 TBE buffer.
Complexes were revealed by autoradiography. Sequences of the
probes are available upon request
Cross-linking and affinity purification
Cross-linking experiments were performed with probes corre-
sponding to three fragments (a, b and c) covering the entire 180 bp
exon 2a. Each 60 bp fragment, obtained by PCR, was cloned into
the BamHI/EcoRI sites of pGEM2 vector (Promega). The control
probe BBS was obtained by PCR performed on genomic DNA
from UAS-BBS-5.12 flies (generous gift from John Lis). This
fragment containing 2 high affinity binding sites for B52 was
cloned into pGEM2. Radiolabelled RNA probes a, b, c and BBS
were transcribed in vitro with SP6 or T7 RNA polymerase, 1 mgo f
the suitable linearized plasmids, 5 mM[ a-
32P]UTP and 5 mM
[a-
32P]GTP (800 Ci/mmol) in 25 ml reaction mixtures according
to the manufacturer’s instructions (Promega). For UV cross-linking
experiments Kc nuclear extract was pre-incubated for 15 min at
30uC in buffer containing 10 mM Tris (pH 7.5), 10% glycerol,
0.1 mM EDTA, 0.75 mM ATP, 25 mM creatinine phosphate,
1 mM MgCl2, 250 ng tRNA, 1 mM DTT, 40 U RNasin, 30 ng/
ml BSA, then radiolabelled RNA was added and incubated
15 min. Reactions were irradiated for 20 min on ice with UV light
(254 nm) at a distance of 3 cm. The RNA was digested with
RNase A and T1 for 30 min at 37uC. Cross-linked proteins were
separated on 10% SDS-PAGE. Dried gels were exposed to
Phosphorimager.
Binding experiments with RNA probes immobilized on agarose
beads were performed essentially as described by Caputi et al [60].
Substrate RNAs for bead immobilization were synthesized in vitro
by using the SP6 or T7 Ribomax large scale RNA production
system (Promega). Following incubation with the splicing mix;
bound proteins were eluted by addition of sample buffer, heated
for 5 min at 90uC, and separated on 12% SDS-PAGE. Western-
blot was performed using antibodies against B52 and dASF.
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